Hosted on MSN

Illumina fined $9.8M for selling DNA sequencers with cybersecurity flaws to U.S. agencies

Illumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic sequencing systems with serious cybersecurity flaws to U.S. federal agencies.
Reuters

Illumina sued by rival Element over gene-sequencing technology

Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...